Compared to patients with LRRK2-PD, the median AAO of patients with non-LRRK2-PD was approximately two years older in both the EUR (HR=0.82, 95% CI: 0.68–0.98, p=0.033) and AJ (HR=0.80, 95% CI: 0.72–0.90, p=2.7×10−4) ancestry group. The gene discussed is LRRK2; the disease is Parkinson disease.